A kinase-inactive type II TGFβ receptor impairs BMP signaling in human breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 301, Issue 1, 2003, Pages 108-112

  Dumont, Nancy ^a   Arteaga, Carlos L ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Bone morphogenetic protein; Dominant negative type II TGF receptor; Signaling, MDA MB 231; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; MUTANT PROTEIN; PHOSPHOTRANSFERASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0037474525     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02977-7     Document Type: Article

References (22)

1. N. Dumont, A.V. Bakin, C.L. Arteaga, Autocrine TGF β signaling mediates Smad-independent motility in human cancer cells. J. Biol. Chem. (in press).
2. ten Dijke P., Yamashita H., Ichijo H., Franzen P., Laiho M., Miyazono K., Heldin C.H. Characterization of type I receptors for transforming growth factor-. β and activin Science. 264:1994;101-104.
3. Attisano L., Wrana J.L., Montalvo E., Massague J. Activation of signalling by the activin receptor complex. Mol. Cell. Biol. 16:1996;1066-1073.
4. de Winter J.P., Roelen B.A., ten Dijke P., van der Burg B., van den Eijnden van Raaij A.J. DPC4 (SMAD4) mediates transforming growth factor-. β 1 (TGF- β 1) induced growth inhibition and transcriptional response in breast tumour cells Oncogene. 14:1997;1891-1899.
5. Kalkhoven E., Roelen B.A., de Winter J.P., Mummery C.L., van den Eijnden-van Raaij A.J., van der Saag P.T., van der Burg B. Resistance to transforming growth factor. β and activin due to reduced receptor expression in human breast tumor cell lines Cell Growth Differ. 6:1995;1151-1161.
6. Arnold S.F., Tims E., Mcgrath B.E. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine. 11:1999;1031-1037.
7. Ghosh-Choudhury N., Woodruff K., Qi W., Celeste A., Abboud S.L., Ghosh Choudhury G. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Biochem. Biophys. Res. Commun. 272:2000;705-711.
8. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-. β /BMP signaling J. Cell. Physiol. 187:2001;265-276.
9. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science. 242:1988;1528-1534.
10. Wozney J.M. The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. Eur. J. Oral Sci. 106(Suppl. 1):1998;160-166.
11. Pouliot F., Labrie C. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. J. Endocrinol. 172:2002;187-198.
12. Phippard D.J., Weber-Hall S.J., Sharpe P.T., Naylor M.S., Jayatalake H., Maas R., Woo I., Roberts-Clark D., Francis-West P.H., Liu Y.H., Maxson R., Hill R.E., Dale T.C. Regulation of Msx-1, Msx-2, Bmp-2, and Bmp-4 during foetal and postnatal mammary gland development. Development. 122:1996;2729-2737.
13. Clement J.H., Marr N., Meissner A., Schwalbe M., Sebald W., Kliche K.O., Hoffken K., Wolfl S. Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J. Cancer Res. Clin. Oncol. 126:2000;271-279.
14. Kim I.Y., Lee D.H., Ahn H.J., Tokunaga H., Song W., Devereaux L.M., Jin D., Sampath T.K., Morton R.A. Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Res. 60:2000;2840-2844.
15. Kleeff J., Maruyama H., Ishiwata T., Sawhney H., Friess H., Buchler M.W., Korc M. Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology. 116:1999;1202-1216.
16. Gobbi G., Sangiorgi L., Lenzi L., Casadei R., Canaider S., Strippoli P., Lucarelli E., Ghedini I., Donati D., Fabbri N., Warzecha J., Yeoung C., Helman L.J., Picci P., Carinci P. Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells. Int. J. Oncol. 20:2002;143-147.
17. Howe J.R., Bair J.L., Sayed M.G., Anderson M.E., Mitros F.A., Petersen G.M., Velculescu V.E., Traverso G., Vogelstein B. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28:2001;184-187.
18. Jonk L.J., Itoh S., Heldin C.H., ten Dijke P., Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-. β, activin, and bone morphogenetic protein-inducible enhancer J. Biol. Chem. 273:1998;21145-21152.
19. Yamamoto H., Ueno H., Ooshima A., Takeshita A. Adenovirus-mediated transfer of a truncated transforming growth factor-. β (TGF- β ) type II receptor completely and specifically abolishes diverse signaling by TGF- β in vascular wall cells in primary culture J. Biol. Chem. 271:1996;16253-16259.
20. Bottinger E.P., Jakubczak J.L., Roberts I.S., Mumy M., Hemmati P., Bagnall K., Merlino G., Wakefield L.M. Expression of a dominant-negative mutant TGF-. β type II receptor in transgenic mice reveals essential roles for TGF- β in regulation of growth and differentiation in the exocrine pancreas EMBO J. 16:1997;2621-2633.
21. Portella G., Gumming S.A., Liddell J., Cui W., Ireland H., Akhurst R.J., Balmain A. Transforming growth factor. β is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion Cell Growth Differ. 9:1998;393-404.
22. Bhowmick N.A., Zent R., Ghiassi M., McDonnell M., Moses H.L. Integrin. β 1 signaling is necessary for transforming growth factor- β activation of p38MAPK and epithelial plasticity J. Biol. Chem. 276:2001b;46707-46713.